European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- __top__ 【No Login】

Covered with layers of sugars, resins, or polymers.

The document read like a recipe and a contract. Definitions, nomenclature, identity tests, uniformity, dissolution — each heading framed a patient’s expectation. The monograph did not dictate production methods; instead it set measurable thresholds and validated analytical procedures. Complying with it meant a tablet that would behave as intended from factory line to bedside.

A "monograph" in this context is a collection of quality standards for a specific type of product. Monograph 0478 is a "general" monograph, meaning its requirements apply to all tablets that fall under its definition, regardless of their specific active ingredient. These requirements are legally binding within the European Union, mandated by EU Directives 2001/82/EC and 2001/83/EC, which state that marketing authorization applications must comply with Ph. Eur. texts. Consequently, the standards set forth in monograph 0478 are legally enforceable for any tablet product marketed within the EU, a fact that underscores its critical importance for pharmaceutical manufacturers. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

The Ph. Eur. monograph for tablets (0478) plays a critical role in ensuring the quality of tablet products in Europe. By following this monograph, manufacturers can ensure that their products meet the required standards for quality, purity, and strength. The monograph also provides a common language and set of standards for regulatory authorities, manufacturers, and control laboratories to evaluate the quality of tablet products.

Note: This standard explicitly excludes lozenges, chewable oral pastes, or tablets intended for alternative routes like implants or vaginal insertion, which are covered by separate dedicated monographs. Production and Manufacturing Controls Covered with layers of sugars, resins, or polymers

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Revised Ph. Eur. Chapter Tablets - ECA Academy

The European Pharmacopoeia (Ph. Eur.) Monograph 0478 ( ) defines mandatory quality standards, including tests for uniformity, disintegration, and dissolution, to ensure the safety and efficacy of tablets intended for oral administration. Covering various forms, from conventional to modified-release, it mandates specific, rigorous quality control tests to ensure compliance. For a detailed overview, review the ECA Academy article on the topic. The monograph did not dictate production methods; instead

This article provides a detailed examination of the Tablets monograph, exploring its scope, key requirements, and critical updates, as well as its vital role in the global pharmaceutical regulatory framework.

In the pharmaceutical world, the is the gold standard for quality control, and Monograph 0478 is the essential blueprint for anyone manufacturing or testing oral tablets. This general monograph defines exactly what a tablet is and sets the baseline requirements for its production and performance. What is Monograph 0478?

Perhaps the most intriguing part of Monograph 0478 is its flexibility regarding form. It legally defines various tablet types that modern patients take for granted: